As a neurologist both in academics at Stanford and in industry as CMO of Neuropace, Martha Morrell has led the develop­ ment of innovative closed loop, implantable stimulation therapies for brain disorders. Her clinical translation of responsive neurostimulation and Class Ill device development will provide excellent perspective on high impact meritorious innovator projects.